Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 1.000 | |
| 4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.499 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.497 | |
| 1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.494 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.493 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.491 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.491 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.490 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.489 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.488 | |
| 3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.488 | |
| 2jds | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.487 | |
| 4oh4 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.487 | |
| 4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.482 | |
| 3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.480 | |
| 3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.480 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.480 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.479 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.478 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.476 | |
| 3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.476 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.475 | |
| 4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.474 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.472 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.471 | |
| 3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.469 | |
| 4j98 | ACP | Fibroblast growth factor receptor 2 | / | 0.469 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.467 | |
| 3nie | ANP | Mitogen-activated protein kinase | / | 0.467 | |
| 3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.467 | |
| 4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.465 | |
| 1j1b | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.464 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.464 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.464 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.464 | |
| 4ocv | ANP | Aminoglycoside phosphotransferase | / | 0.464 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.463 | |
| 1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.463 | |
| 4e6d | 0NU | Tyrosine-protein kinase JAK2 | / | 0.463 | |
| 1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.462 | |
| 2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.461 | |
| 3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
| 4f9b | 0SY | Cell division cycle 7-related protein kinase | 2.7.11.1 | 0.461 | |
| 4f9c | 0SX | Cell division cycle 7-related protein kinase | 2.7.11.1 | 0.461 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.461 | |
| 2pvm | P29 | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
| 1w0x | OLO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.459 | |
| 4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
| 3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.458 | |
| 1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.457 | |
| 2gnh | H52 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.456 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.456 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.456 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.455 | |
| 4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.455 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.454 | |
| 3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.454 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
| 1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.453 | |
| 1q8t | Y27 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
| 1ydr | IQP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
| 3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.453 | |
| 3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.453 | |
| 2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.452 | |
| 4ock | ANP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.452 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
| 4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
| 4lfi | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
| 2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
| 2uw0 | GVK | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.450 | |
| 2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 3ncz | 3NC | Rho-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.450 | |
| 1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.449 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.449 | |
| 1pnv | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.448 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
| 3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
| 4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.448 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.448 | |
| 1q8u | H52 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
| 2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
| 2uzw | SS4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
| 2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.446 | |
| 1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
| 2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.445 | |
| 2vo6 | M05 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
| 2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
| 4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
| 3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.444 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.444 | |
| 4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.444 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.443 | |
| 1ydt | IQB | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
| 3oog | YTP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
| 3r1y | X76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.441 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.441 | |
| 4m69 | ANP | Receptor-interacting serine/threonine-protein kinase 3 | 2.7.11.1 | 0.440 | |
| 4pl4 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.440 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.440 |